1-6 of 6
Teresa L. Burgess
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In Vitro and In Vivo Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models

Paul E. Hughes, Karen Rex, Sean Caenepeel, Yajing Yang, Yihong Zhang, Martin A. Broome, Hue T. Kha, Teresa L. Burgess, Benny Amore, Paula J. Kaplan-Lefko, Jodi Moriguchi, Jonathan Werner, Michael A. Damore, Daniel Baker, Deborah M. Choquette, Jean-Christophe Harmange, Robert Radinsky, Richard Kendall, Isabelle Dussault, Angela Coxon
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (7): 1568–1579.
https://doi.org/10.1158/1535-7163.MCT-15-0871
Published: 05 July 2016
View article titled, <em>In Vitro</em> and <em>In Vivo</em> Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models
Open the PDF for <em>In Vitro</em> and <em>In Vivo</em> Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models in another window
Includes: Supplementary data
Journal Articles

Abstract A204: A cellular model of acquired resistance to rilotumumab (AMG 102) in glioblastoma.

Fabiola Cecchi, Karen Rex, Joanna Schmidt, Daniel Baker, Michael A. Damore, Angela Coxon, Teresa L. Burgess, Donald P. Bottaro
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): A204.
https://doi.org/10.1158/1535-7163.TARG-11-A204
Published: 12 November 2011
View article titled, Abstract A204: A cellular model of acquired resistance to rilotumumab (AMG 102) in glioblastoma.
Journal Articles

Selective and Potent Raf Inhibitors Paradoxically Stimulate Normal Cell Proliferation and Tumor Growth

Josette Carnahan, Pedro J. Beltran, Carol Babij, Quynh Le, Mark J. Rose, Steven Vonderfecht, Joseph L. Kim, Adrian L. Smith, Karthik Nagapudi, Martin A. Broome, Manory Fernando, Hue Kha, Brian Belmontes, Robert Radinsky, Richard Kendall, Teresa L. Burgess
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (8): 2399–2410.
https://doi.org/10.1158/1535-7163.MCT-10-0181
Published: 09 August 2010
View article titled, Selective and Potent Raf Inhibitors Paradoxically Stimulate Normal Cell Proliferation and Tumor Growth
Open the PDF for Selective and Potent Raf Inhibitors Paradoxically Stimulate Normal Cell Proliferation and Tumor Growth in another window
Includes: Supplementary data
Journal Articles

Biochemical Characterization of AMG 102: A Neutralizing, Fully Human Monoclonal Antibody to Human and Nonhuman Primate Hepatocyte Growth Factor

Teresa L. Burgess, Jan Sun, Susanne Meyer, Trace S. Tsuruda, Jilin Sun, Gary Elliott, Qing Chen, Mitsuru Haniu, Will F. Barron, Todd Juan, Ke Zhang, Angela Coxon, Richard L. Kendall
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (2): 400–409.
https://doi.org/10.1158/1535-7163.MCT-09-0824
Published: 09 February 2010
View article titled, Biochemical Characterization of AMG 102: A Neutralizing, Fully Human Monoclonal Antibody to Human and Nonhuman Primate Hepatocyte Growth Factor
Open the PDF for Biochemical Characterization of AMG 102: A Neutralizing, Fully Human Monoclonal Antibody to Human and Nonhuman Primate Hepatocyte Growth Factor in another window
Includes: Supplementary data
Journal Articles

Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: Inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma

Chong-Feng Gao, Qian Xie, Yu-Wen Zhang, Yanli Su, Ping Zhao, Brian Cao, Kyle Furge, Jan Sun, Karen Rex, Tao Osgood, Angela Coxon, Teresa L. Burgess, George F. Vande Woude
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (10): 2803–2810.
https://doi.org/10.1158/1535-7163.MCT-09-0125
Published: 12 October 2009
View article titled, Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: Inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma
Open the PDF for Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: Inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma in another window
Journal Articles

Soluble c-Met receptors inhibit phosphorylation of c-Met and growth of hepatocyte growth factor: c-Met–dependent tumors in animal models

Angela Coxon, Karen Rex, Susanne Meyer, Jianling Sun, Jilin Sun, Qing Chen, Robert Radinsky, Richard Kendall, Teresa L. Burgess
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (5): 1119–1125.
https://doi.org/10.1158/1535-7163.MCT-08-1032
Published: 13 May 2009
View article titled, Soluble c-Met receptors inhibit phosphorylation of c-Met and growth of hepatocyte growth factor: c-Met–dependent tumors in animal models
Open the PDF for Soluble c-Met receptors inhibit phosphorylation of c-Met and growth of hepatocyte growth factor: c-Met–dependent tumors in animal models in another window